
Cybille Delacroix Muirhei
Examiner (ID: 18979)
| Most Active Art Unit | 1614 |
| Art Unit(s) | 1102, 1614, 1654, 1811 |
| Total Applications | 893 |
| Issued Applications | 513 |
| Pending Applications | 176 |
| Abandoned Applications | 204 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4262420
[patent_doc_number] => 06306437
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-10-23
[patent_title] => 'Apomorphine-containing dosage forms for ameliorating male erectile dysfunction'
[patent_app_type] => 1
[patent_app_number] => 9/606919
[patent_app_country] => US
[patent_app_date] => 2000-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 16194
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/306/06306437.pdf
[firstpage_image] =>[orig_patent_app_number] => 606919
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/606919 | Apomorphine-containing dosage forms for ameliorating male erectile dysfunction | Jun 28, 2000 | Issued |
| 09/509699 | POSTSURGICAL TREATMENT WITH DICHLOROACETATE | Jun 25, 2000 | Abandoned |
Array
(
[id] => 1528523
[patent_doc_number] => 06479555
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Method for inducing hepatic fibrosis by repeated administration of allylalcohol'
[patent_app_type] => B1
[patent_app_number] => 09/598880
[patent_app_country] => US
[patent_app_date] => 2000-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4470
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479555.pdf
[firstpage_image] =>[orig_patent_app_number] => 09598880
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/598880 | Method for inducing hepatic fibrosis by repeated administration of allylalcohol | Jun 20, 2000 | Issued |
Array
(
[id] => 1281928
[patent_doc_number] => 06642243
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-04
[patent_title] => 'Migraine medicine and method for treating same'
[patent_app_type] => B1
[patent_app_number] => 09/593238
[patent_app_country] => US
[patent_app_date] => 2000-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3468
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/642/06642243.pdf
[firstpage_image] =>[orig_patent_app_number] => 09593238
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/593238 | Migraine medicine and method for treating same | Jun 13, 2000 | Issued |
Array
(
[id] => 1528399
[patent_doc_number] => 06479509
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Method of promoting smoking cessation'
[patent_app_type] => B1
[patent_app_number] => 09/575800
[patent_app_country] => US
[patent_app_date] => 2000-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9664
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 497
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479509.pdf
[firstpage_image] =>[orig_patent_app_number] => 09575800
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/575800 | Method of promoting smoking cessation | May 21, 2000 | Issued |
Array
(
[id] => 1369846
[patent_doc_number] => 06566395
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-20
[patent_title] => 'Methods of treating proliferative disorders'
[patent_app_type] => B1
[patent_app_number] => 09/577689
[patent_app_country] => US
[patent_app_date] => 2000-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9653
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/566/06566395.pdf
[firstpage_image] =>[orig_patent_app_number] => 09577689
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/577689 | Methods of treating proliferative disorders | May 21, 2000 | Issued |
Array
(
[id] => 1532964
[patent_doc_number] => 06410513
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-25
[patent_title] => 'Glucagon-like insulinotropic peptides, compositions and methods'
[patent_app_type] => B1
[patent_app_number] => 09/573809
[patent_app_country] => US
[patent_app_date] => 2000-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6731
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/410/06410513.pdf
[firstpage_image] =>[orig_patent_app_number] => 09573809
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/573809 | Glucagon-like insulinotropic peptides, compositions and methods | May 17, 2000 | Issued |
Array
(
[id] => 1271062
[patent_doc_number] => 06653336
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-11-25
[patent_title] => 'Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders'
[patent_app_type] => B1
[patent_app_number] => 09/554715
[patent_app_country] => US
[patent_app_date] => 2000-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2498
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/653/06653336.pdf
[firstpage_image] =>[orig_patent_app_number] => 09554715
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/554715 | Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders | May 17, 2000 | Issued |
Array
(
[id] => 1343188
[patent_doc_number] => 06586458
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-01
[patent_title] => 'Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs'
[patent_app_type] => B1
[patent_app_number] => 09/559753
[patent_app_country] => US
[patent_app_date] => 2000-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6380
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/586/06586458.pdf
[firstpage_image] =>[orig_patent_app_number] => 09559753
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/559753 | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs | Apr 26, 2000 | Issued |
Array
(
[id] => 1363313
[patent_doc_number] => 06569852
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-27
[patent_title] => 'Coatings and soaks for medical prosthetic devices comprising taurinamide derivatives and carboxylic acids and/or salts thereof'
[patent_app_type] => B1
[patent_app_number] => 09/552198
[patent_app_country] => US
[patent_app_date] => 2000-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7086
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/569/06569852.pdf
[firstpage_image] =>[orig_patent_app_number] => 09552198
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/552198 | Coatings and soaks for medical prosthetic devices comprising taurinamide derivatives and carboxylic acids and/or salts thereof | Apr 18, 2000 | Issued |
Array
(
[id] => 1560360
[patent_doc_number] => 06436969
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-20
[patent_title] => 'Dialysis solutions and methods'
[patent_app_type] => B1
[patent_app_number] => 09/544416
[patent_app_country] => US
[patent_app_date] => 2000-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 57
[patent_figures_cnt] => 88
[patent_no_of_words] => 21531
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/436/06436969.pdf
[firstpage_image] =>[orig_patent_app_number] => 09544416
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/544416 | Dialysis solutions and methods | Apr 5, 2000 | Issued |
Array
(
[id] => 1246234
[patent_doc_number] => 06677430
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-01-13
[patent_title] => 'Fluorescent motilin peptides'
[patent_app_type] => B1
[patent_app_number] => 09/539593
[patent_app_country] => US
[patent_app_date] => 2000-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 8539
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/677/06677430.pdf
[firstpage_image] =>[orig_patent_app_number] => 09539593
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/539593 | Fluorescent motilin peptides | Mar 30, 2000 | Issued |
Array
(
[id] => 1602962
[patent_doc_number] => 06433141
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-13
[patent_title] => 'Purified heat shock protein complexes'
[patent_app_type] => B1
[patent_app_number] => 09/534381
[patent_app_country] => US
[patent_app_date] => 2000-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2336
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/433/06433141.pdf
[firstpage_image] =>[orig_patent_app_number] => 09534381
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/534381 | Purified heat shock protein complexes | Mar 23, 2000 | Issued |
Array
(
[id] => 1528426
[patent_doc_number] => 06479520
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/520395
[patent_app_country] => US
[patent_app_date] => 2000-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9578
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479520.pdf
[firstpage_image] =>[orig_patent_app_number] => 09520395
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/520395 | Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives | Mar 7, 2000 | Issued |
Array
(
[id] => 1602832
[patent_doc_number] => 06433011
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-13
[patent_title] => 'Method for inhibiting formation of aberrant crypt foci in the colon of a mammal'
[patent_app_type] => B1
[patent_app_number] => 09/520513
[patent_app_country] => US
[patent_app_date] => 2000-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3968
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/433/06433011.pdf
[firstpage_image] =>[orig_patent_app_number] => 09520513
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/520513 | Method for inhibiting formation of aberrant crypt foci in the colon of a mammal | Mar 7, 2000 | Issued |
| 09/521180 | Method for using lipoprotein associated coagulation inhibitor to treat sepsis | Mar 7, 2000 | Abandoned |
Array
(
[id] => 7609719
[patent_doc_number] => 06998470
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-02-14
[patent_title] => 'Process for large-scale isolation and purification of hypothalamic inhibitory factor'
[patent_app_type] => utility
[patent_app_number] => 09/506246
[patent_app_country] => US
[patent_app_date] => 2000-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6329
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/998/06998470.pdf
[firstpage_image] =>[orig_patent_app_number] => 09506246
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/506246 | Process for large-scale isolation and purification of hypothalamic inhibitory factor | Feb 16, 2000 | Issued |
Array
(
[id] => 1435996
[patent_doc_number] => 06355639
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-12
[patent_title] => 'Reverse prenyl compounds as immunosuppressants'
[patent_app_type] => B1
[patent_app_number] => 09/463537
[patent_app_country] => US
[patent_app_date] => 2000-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7946
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/355/06355639.pdf
[firstpage_image] =>[orig_patent_app_number] => 09463537
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/463537 | Reverse prenyl compounds as immunosuppressants | Feb 15, 2000 | Issued |
Array
(
[id] => 1545719
[patent_doc_number] => 06444646
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-03
[patent_title] => 'Use of angiotensin II type 2 receptor agonists in tissue repair'
[patent_app_type] => B1
[patent_app_number] => 09/503872
[patent_app_country] => US
[patent_app_date] => 2000-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4947
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/444/06444646.pdf
[firstpage_image] =>[orig_patent_app_number] => 09503872
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/503872 | Use of angiotensin II type 2 receptor agonists in tissue repair | Feb 13, 2000 | Issued |
Array
(
[id] => 1415712
[patent_doc_number] => 06521591
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-18
[patent_title] => 'Pharmaceutical composition for muscular anabolism'
[patent_app_type] => B1
[patent_app_number] => 09/500802
[patent_app_country] => US
[patent_app_date] => 2000-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2936
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/521/06521591.pdf
[firstpage_image] =>[orig_patent_app_number] => 09500802
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/500802 | Pharmaceutical composition for muscular anabolism | Feb 9, 2000 | Issued |